E. Truelove, A. Fielding, and B. Hunt, The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia, Leukemia, vol.90, issue.3, pp.553-559, 2013.
DOI : 10.1111/j.1365-2141.2006.06209.x

V. Caruso, L. Iacoviello, D. Castelnuovo, and A. , Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients, Blood, vol.108, issue.7, pp.2216-2222, 2006.
DOI : 10.1182/blood-2006-04-015511

V. Caruso, L. Iacoviello, D. Castelnuovo, and A. , Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis, Journal of Thrombosis and Haemostasis, vol.80, issue.3, pp.621-623, 2007.
DOI : 10.1111/j.1538-7836.2007.02383.x

J. Stam, Thrombosis of the Cerebral Veins and Sinuses, New England Journal of Medicine, vol.352, issue.17, pp.1791-1798, 2005.
DOI : 10.1056/NEJMra042354

L. Clavell, R. Gelber, and H. Cohen, Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia, New England Journal of Medicine, vol.315, issue.11, pp.657-663, 1986.
DOI : 10.1056/NEJM198609113151101

M. Duval, S. Suciu, and A. Ferster, Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer---Children's Leukemia Group phase 3 trial, Blood, vol.99, issue.8, pp.2734-2739, 2002.
DOI : 10.1182/blood.V99.8.2734

E. Nagura, K. Kimura, and K. Yamada, Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia, Cancer Chemotherapy and Pharmacology, vol.1, issue.5, pp.359-365, 1994.
DOI : 10.1007/BF00686263

L. Mitchell, H. Hoogendoorn, and A. Giles, Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L- Asparaginase-induced antithrombin III deficiency, Blood, vol.83, pp.386-391, 1994.

L. Mitchell, J. Halton, and P. Vegh, Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia, Am J Pediatr Hematol Oncol, vol.16, pp.120-126, 1994.

M. Andrew, L. Brooker, and L. Mitchell, Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia, Blood Coagulation & Fibrinolysis, vol.5, issue.1, pp.24-36, 1994.
DOI : 10.1097/00001721-199401000-00005

L. Mitchell, A. Sutor, and M. Andrew, Hemostasis in Childhood Acute Lymphoblastic Leukemia: Coagulopathy Induced by Disease and Treatment, Seminars in Thrombosis and Hemostasis, vol.21, issue.04, pp.390-401, 1995.
DOI : 10.1055/s-2007-1000660

G. Leone, L. Gugliotta, and M. Mazzucconi, Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study, Thromb Haemost, vol.69, pp.12-15, 1993.

S. Lepretre, A. Touzart, and T. Vermeulin, Pediatric ALL-like therapy for adults with T-cell lymphoblastic lymphoma: Results of the Graall-Lysa LL03 study, ASH Annual Meeting Abstracts, 2014.

F. Huguet, T. Leguay, and E. Raffoux, Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome???Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study, Journal of Clinical Oncology, vol.27, issue.6, pp.911-918, 2009.
DOI : 10.1200/JCO.2008.18.6916

N. Dhédin, A. Huynh, and S. Maury, Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia, Blood, vol.125, issue.16, pp.2486-2496, 2015.
DOI : 10.1182/blood-2014-09-599894

M. Hunault-berger, P. Chevallier, and M. Delain, Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study, Haematologica, vol.93, issue.10, pp.1488-1494, 2008.
DOI : 10.3324/haematol.12948

A. Qureshi, C. Mitchell, and S. Richards, Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe, British Journal of Haematology, vol.112, issue.3, pp.410-413, 2010.
DOI : 10.1111/j.1365-2141.2010.08132.x

L. Abbott, M. Deevska, and C. Fernandez, The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase, Blood, vol.114, issue.25, pp.5146-5151, 2009.
DOI : 10.1182/blood-2009-07-231084

S. Ranta, R. Tuckuviene, and A. Mäkipernaa, Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology, British Journal of Haematology, vol.23, issue.4, pp.10-1111, 2014.
DOI : 10.1111/bjh.13162

R. Grace, S. Dahlberg, and D. Neuberg, The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols, British Journal of Haematology, vol.54, issue.2, pp.452-459, 2011.
DOI : 10.1111/j.1365-2141.2010.08524.x

U. Athale, S. Siciliano, and M. Crowther, Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease, British Journal of Haematology, vol.47, issue.6, pp.803-810, 2005.
DOI : 10.1182/blood.V97.5.1211

R. Bertina, B. Koeleman, and T. Koster, Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature, vol.369, issue.6475, pp.64-67, 1994.
DOI : 10.1038/369064a0

R. Franco and P. Reitsma, Genetic risk factors of venous thrombosis, Human Genetics, vol.109, issue.4, pp.369-384, 2001.
DOI : 10.1007/s004390100593

E. Wysokinska, W. Wysokinski, and R. Brown, Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis, Neurology, vol.70, issue.8, pp.627-633, 2008.
DOI : 10.1212/01.wnl.0000297195.97325.a8

F. Dentali, M. Crowther, and W. Ageno, Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis, Blood, vol.107, issue.7, pp.2766-2773, 2006.
DOI : 10.1182/blood-2005-09-3578

M. Elliott, R. Wolf, and C. Hook, Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin, Leukemia & Lymphoma, vol.12, issue.5, pp.1545-1549, 2004.
DOI : 10.1080/08880010050211376

D. Stefano, V. Sorà, F. Rossi, and E. , The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment, Journal of Thrombosis and Haemostasis, vol.16, issue.Suppl. 1, pp.1985-1992, 2005.
DOI : 10.1111/j.1538-7836.2005.01467.x

J. Payne and A. Vora, Thrombosis and acute lymphoblastic leukaemia, British Journal of Haematology, vol.211, issue.4, pp.430-445, 2007.
DOI : 10.1016/j.thromres.2004.07.016